Dave Gardella
Analyst · CJS Securities. Please go ahead
Thanks, Dan, and good morning, everyone. As Dan mentioned softness in market activity of US capital market transactions resulted in weaker than expected revenue in the quarter. However, despite a year-over-year revenue decline, we grew our non-GAAP adjusted EBITDA in the quarter by 8.8% compared to last year through cost actions we implemented late last year and throughout this year. Net sales for the third quarter were $222.6 million, a decrease of $1.8 million or 0.8% from the third quarter of 2016. After adjusting for changes in foreign exchange rates, organic sales decreased 0.9% driven by the decline in our U.S. segment, which was partially offset by organic growth of 12.8% in our international segment. The revenue decline in our U.S. segment was driven by lower capital markets transactions volume and lower healthcare print volume, partially offset by higher compliance volume, growth in our software offerings and higher mutual funds volume. Our international segment revenue growth was primarily driven by higher mutual funds volume as well as growth in our language solutions translation services. Third quarter gross margin was 36.8% or 208 basis points higher than the third quarter of 2016. This includes approximately 300 basis points of a negative impact driven by a change in the classification of IT cost to cost of sales from SG&A compared to the classifications in periods prior to the separation from R.R. Donnelley. Excluding this reclassification, the third quarter gross margin improvement of approximately 508 basis points was primarily driven by cost reductions we began to implement late last year, as well as lower outsourcing cost. Non-GAAP SG&A expense in the quarter was $59.7 million, $1.4 million higher than the third quarter of 2016. As a percentage of revenue, SG&A was 22.3% or 80 basis points higher than the third quarter of 2016. Excluding the favorable 300 basis point impact of the IT reclassification, SG&A as a percentage of revenue was approximately 380 basis points higher than the third quarter of 2016. As noted in this morning's press release, we incurred approximately $5.3 million in higher cost related to dis-synergies and ongoing costs in excess of the cost allocated to the company prior to the spin-off from RR Donnelley. Our third quarter non-GAAP adjusted EBITDA was $32.3 million, an increase of $2.6 million from the third quarter of 2016. Non-GAAP adjusted EBITDA margin in the quarter of 14.5% was 128 basis points higher than the third quarter of last year, primarily driven by our cost reduction actions which were partially offset by lower transactional volume and higher cost driven by the separation from RR Donnelley. Now I'll discuss revenue and non-GAAP adjusted EBITDA performance for each of our segments. Revenue in our U.S. segment was $186.1 million in the third quarter of 2017, a decrease of 3.2% from last year’s third quarter. Our capital markets revenue declined 4.7% primarily driven by lower transactional revenue related to M&A. The decline in transactional was only partially offset by a couple of large compliance deals we recognized in the third quarter of 2017, as well as continued growth in our Venue and ActiveDisclosure software offerings. Investment markets revenue declined 2.9% to the third quarter of last year, driven by lower healthcare print volume as well as lower content management volume, partially offset by higher mutual funds volume. Language solutions and other reported revenue growth of 8.2%, driven by higher commercial print volume. Non-GAAP adjusted EBITDA margin for the segment of 17.7% increased 286 basis points from the third quarter of 2016. The improvement in EBITDA margin was mainly driven by our cost saving actions as well as lower outsourcing cost compared to the third quarter of last year. Revenue in our international segment was $36.5 million in the third quarter of 2017, an increase of 13.7% from the third quarter of last year. On an organic basis, excluding the favorable impact of changes in foreign exchange rate, revenue in the third quarter increased 12.8% which was driven by higher volume in our mutual funds and translations services. Non-GAAP adjusted EBITDA margin for the segment of 8.2% increased 43 basis points from the third quarter of 2016. Higher mutual funds volume and the impact of cost savings actions were partially offset by a higher allocation of IT expenses. Our third quarter 2017 non-GAAP unallocated corporate expenses excluding deprecation and amortization were $3.7 million; an increase of $2.3 million from the third quarter of 2016, this increase was driven by dis-synergies related to the separation from R.R. Donnelley which were partially offset by cost saving initiatives. Free cash flow in the quarter was $65.1 million, a decline of $23.6 million from the third quarter of last year, driven by tax and interest payments in the quarter, as well as more cash used in working capital and higher capital expenditures. On October 2nd, we reprised our term loan with an outstanding balance of $200 million and reduced our interest rate by 100 basis points to LIBOR PLUS 300. We also reduced our debt in the quarter by $37.5 million and ended the quarter with $488.4 million of total debt and $32.2 million of cash. As of September 30th, our gross leverage was 3.9x compared to 3.6x at December 31, 2016, and we had net available liquidity of $293.2 million at the end of the third quarter. Since the spin-off, we have reduced our total debt by $148.1 million and remain on track to be within our targeted leverage range of 2.25x to 2.75x by the end of the year. As we enter to the last quarter of the year, let me share more detail on the updated full year 2017 guidance that was summarized in this morning's press release. Our updated guidance reflects the softer than expected environment for capital markets transaction that we experienced in the third quarter and a more conservative outlook for the fourth quarter relative to our previous expectations. We expect revenue of approximately $1 billion, representing organic growth in the range of 2% to 3%, a decrease of 150 basis points from previous guidance which I just noted reflects our third quarter performance and more conservative outlook of market activity for the remainder of the year. We expect our non-GAAP adjusted EBITDA to be approximately $170 million; $7.5 million lower than the midpoint of our previous guidance. Depreciation and amortization is expected to be approximately $43. We continue to expect interest expense of approximately $43 million. Our full year non-GAAP tax rate is expected to be in the range of 40% to 42%. We project the full year fully diluted weighted average share count to be approximately 33 million shares. And lastly, we expect capital expenditures in the range of $30 million to $35 million and free cash flow of approximately $50 million. And with that I'll turn it back to Dan.